IL22 and steatosis: Our data indicated that the beneficial effects of IL‐22 on HFD‐induced renal injury, necrosis, steatosis, mitochondrial dysfunction, and ROS accumulation and the activation of related signaling pathways were significantly blocked by PFKFB3 knockdown (Figure 6B–G).